AXGN FY 2022 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

FY 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$139M+8.8% YoY

Gross Profit

$109M78.5% margin

Operating Income

-$30M-21.4% margin

Net Income

-$29M-20.9% margin

EPS (Diluted)

$-0.69

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$37M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$195M

Total Liabilities

$94M

Stockholders' Equity

$101M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$127M	+8.8%
Gross Profit	$109M	$104M	+4.2%
Operating Income	-$30M	-$25M	-16.9%
Net Income	-$29M	-$27M	-7.3%